Form 8-K - Current report:
SEC Accession No. 0001641172-25-025898
Filing Date
2025-08-29
Accepted
2025-08-29 08:45:35
Documents
15
Period of Report
2025-08-25
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K form8-k.htm   iXBRL 8-K 48904
2 EX-10.1 ex10-1.htm EX-10.1 73629
3 EX-99.1 ex99-1.htm EX-99.1 13166
4 GRAPHIC ex99-1.jpg GRAPHIC 5097
  Complete submission text file 0001641172-25-025898.txt   327620

Data Files

Seq Description Document Type Size
5 XBRL SCHEMA FILE balancelabsco-20250825.xsd EX-101.SCH 3017
6 XBRL LABEL FILE balancelabsco-20250825_lab.xml EX-101.LAB 34239
7 XBRL PRESENTATION FILE balancelabsco-20250825_pre.xml EX-101.PRE 22351
17 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3357
Mailing Address 407 LINCOLN ROAD SUITE 701 MIAMI BEACH FL 33139
Business Address 1111 LINCOLN ROAD 4TH FLOOR MIAMI FL 33139 (305) 907-7600
Balance Labs, Inc. (Filer) CIK: 0001632121 (see all company filings)

EIN.: 471146785 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 333-202959 | Film No.: 251276327
SIC: 8742 Services-Management Consulting Services
(CF Office: 07 Trade & Services)